Eric Groen - 27 Mar 2023 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
GENERAL COUNSEL
Signature
/s/ Josh Seidenfeld, , Attorney-in-Fact
Issuer symbol
RANI
Transactions as of
27 Mar 2023
Net transactions value
$0
Form type
4
Filing time
29 Mar 2023, 21:12:44 UTC
Previous filing
24 Mar 2023
Next filing
19 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RANI Class A Common Stock Award $0 +139,000 +574% $0.000000 163,216 27 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RANI Stock Option (Right to Buy) Award $0 +205,800 $0.000000 205,800 27 Mar 2023 Class A Common Stock 205,800 $5.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the restricted stock unit grant vest as follows: 1/16th of the RSUs shall vest quarterly over four years from March 27, 2023.
F2 The shares subject to the option vest as follows: 1/4th of the shares subject to the option vest monthly over four years from March 27, 2023.